Marc S. Raab

12.1k total citations · 2 hit papers
201 papers, 5.5k citations indexed

About

Marc S. Raab is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Marc S. Raab has authored 201 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 171 papers in Hematology, 116 papers in Molecular Biology and 89 papers in Oncology. Recurrent topics in Marc S. Raab's work include Multiple Myeloma Research and Treatments (169 papers), Protein Degradation and Inhibitors (60 papers) and Peptidase Inhibition and Analysis (44 papers). Marc S. Raab is often cited by papers focused on Multiple Myeloma Research and Treatments (169 papers), Protein Degradation and Inhibitors (60 papers) and Peptidase Inhibition and Analysis (44 papers). Marc S. Raab collaborates with scholars based in Germany, United States and France. Marc S. Raab's co-authors include Kenneth C. Anderson, Paul G. Richardson, Hartmut Goldschmidt, Klaus Podar, Iris Breitkreutz, Dirk Hose, Anna Jauch, Anthony D. Ho, Jens Hillengaß and Dharminder Chauhan and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Marc S. Raab

187 papers receiving 5.4k citations

Hit Papers

Multiple myeloma 2009 2026 2014 2020 2009 2018 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Multiple myeloma
    2009 533 citations Marc S. Raab, Klaus Podar et al. profile →
  2. Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma
    2018 364 citations Meletios Α. Dimopoulos, Philippe Moreau et al. profile →

Peers

Marc S. Raab
Suzanne Trudel Canada
Andrzej Jakubowiak United States
Nizar J. Bahlis Canada
Laurence Catley United States
Michael Kauffman United States
Mariateresa Fulciniti United States
Ivana Gojo United States
Lynn C. Moscinski United States
Kenneth H. Shain United States
Emma Shtivelman United States
Suzanne Trudel Canada
Marc S. Raab
Citations per year, relative to Marc S. Raab Marc S. Raab (= 1×) peers Suzanne Trudel

Countries citing papers authored by Marc S. Raab

Since Specialization
Citations

This map shows the geographic impact of Marc S. Raab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc S. Raab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc S. Raab more than expected).

Fields of papers citing papers by Marc S. Raab

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc S. Raab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc S. Raab. The network helps show where Marc S. Raab may publish in the future.

Co-authorship network of co-authors of Marc S. Raab

This figure shows the co-authorship network connecting the top 25 collaborators of Marc S. Raab. A scholar is included among the top collaborators of Marc S. Raab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc S. Raab. Marc S. Raab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roll, M., Götz Gelbrich, Johannes M. Waldschmidt, et al.. (2025). Talquetamab‐Related Dysgeusia in Multiple Myeloma Compared to BCMA ‐Targeted Bispecifics and High‐Dose Melphalan. Cancer Medicine. 14(23). e71401–e71401.
2.
Schinke, Carolina, Leo Rasche, Marc S. Raab, & Niels Weinhold. (2024). Impact of Clonal Heterogeneity in Multiple Myeloma. Hematology/Oncology Clinics of North America. 38(2). 461–476. 1 indexed citations
3.
Hielscher, Thomas, Iris Breitkreutz, Sandra Sauer, et al.. (2024). Longitudinal assessment of established risk stratification models in patients with monoclonal gammopathy of undetermined significance. Blood Cancer Journal. 14(1). 148–148. 1 indexed citations
4.
John, Lukas, Sandra Sauer, Ute Hegenbart, et al.. (2023). Idecabtagene Vicleucel Is Well Tolerated and Effective in Relapsed/Refractory Myeloma Patients with Prior Allogeneic Stem Cell Transplantation. Transplantation and Cellular Therapy. 29(10). 609.e1–609.e6. 4 indexed citations
5.
6.
Raab, Marc S., Elena Zamagni, Salomon Manier, et al.. (2023). Difficult‐to‐treat patients with relapsed/refractory multiple myeloma: A review of clinical trial results. SHILAP Revista de lepidopterología. 4(4). 1117–1131. 12 indexed citations
7.
Poos, Alexandra M., Marc S. Raab, Hartmut Goldschmidt, et al.. (2023). Comparison of IGLV2‐14 light chain sequences of patients with AL amyloidosis or multiple myeloma. FEBS Journal. 290(17). 4256–4267. 2 indexed citations
8.
9.
Dittrich, Tobias, Martin Schorb, Niels Weinhold, et al.. (2023). High-throughput electron tomography identifies centriole over-elongation as an early event in plasma cell disorders. Leukemia. 37(12). 2468–2478. 2 indexed citations
10.
Vij, Ravi, Rajneesh Nath, Daniel Afar, et al.. (2020). First-in-Human Phase I Study of ABBV-838, an Antibody–Drug Conjugate Targeting SLAMF7/CS1 in Patients with Relapsed and Refractory Multiple Myeloma. Clinical Cancer Research. 26(10). 2308–2317. 24 indexed citations
11.
Breunig, Christian, Anja Baumann, Nicola Giesen, et al.. (2020). HDP-101, an Anti-BCMA Antibody–Drug Conjugate, Safely Delivers Amanitin to Induce Cell Death in Proliferating and Resting Multiple Myeloma Cells. Molecular Cancer Therapeutics. 20(2). 367–378. 61 indexed citations
12.
Sellner, Leopold, Nicola Giesen, Maria‐Luisa Schubert, et al.. (2020). B‐cell maturation antigen‐specific chimeric antigen receptor T cells for multiple myeloma: Clinical experience and future perspectives. International Journal of Cancer. 147(8). 2029–2041. 9 indexed citations
13.
Mohty, Mohamad, Michèle Cavo, Leah Fink, et al.. (2019). Understanding mortality in multiple myeloma: Findings of a European retrospective chart review. European Journal Of Haematology. 103(2). 107–115. 25 indexed citations
14.
Raab, Marc S., Leah Fink, Paul Schoen, et al.. (2018). Evolution of multiple myeloma treatment practices in Europe from 2014 to 2016. British Journal of Haematology. 185(5). 981–984. 17 indexed citations
15.
Breunig, Christian, Nicola Lehners, Anja Baumann, et al.. (2017). Preclinical Evaluation of Hdp-101, a Novel Anti-BCMA Antibody-Drug Conjugate, in Multiple Myeloma. Blood. 130. 3070–3070. 11 indexed citations
16.
Nagai, Tomoaki, Andrey Turchinovich, Natália Becker, et al.. (2016). Pharmacological Inhibition of Centrosome Clustering by Slingshot-Mediated Cofilin Activation and Actin Cortex Destabilization. Cancer Research. 76(22). 6690–6700. 23 indexed citations
17.
Andrulis, Mindaugas, Nicola Lehners, David Capper, et al.. (2013). Targeting the BRAF V600E Mutation in Multiple Myeloma. Cancer Discovery. 3(8). 862–869. 171 indexed citations
18.
Raab, Marc S., Iris Breitkreutz, Simon Anderhub, et al.. (2012). GF-15, a Novel Inhibitor of Centrosomal Clustering, Suppresses Tumor Cell Growth In Vitro and In Vivo. Cancer Research. 72(20). 5374–5385. 56 indexed citations
19.
Zhang, Jing, Martin Sattler, Giovanni Tonon, et al.. (2009). Targeting Angiogenesis via a c-Myc/Hypoxia-Inducible Factor-1α–Dependent Pathway in Multiple Myeloma. Cancer Research. 69(12). 5082–5090. 76 indexed citations
20.
Podar, Klaus, Marc S. Raab, Giovanni Tonon, et al.. (2007). Up-Regulation of c-Jun Inhibits Proliferation and Induces Apoptosis via Caspase-Triggered c-Abl Cleavage in Human Multiple Myeloma. Cancer Research. 67(4). 1680–1688. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suzanne Trudel Breakdown of academic impact, for papers by Andrzej Jakubowiak Breakdown of academic impact, for papers by Nizar J. Bahlis Breakdown of academic impact, for papers by Laurence Catley Breakdown of academic impact, for papers by Michael Kauffman Breakdown of academic impact, for papers by Mariateresa Fulciniti Breakdown of academic impact, for papers by Ivana Gojo Breakdown of academic impact, for papers by Lynn C. Moscinski Breakdown of academic impact, for papers by Kenneth H. Shain Breakdown of academic impact, for papers by Emma Shtivelman
Rankless by CCL
2026